Poland· PL-100425950
Groprinosin Forte
A inosine pranobex product containing inosinum pranobexum, registered in Poland by Gedeon Richter Polska Sp. z o.o.. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Inosine pranobex is registered in 7 of 19 countries.
Countries holding a registration under ATC J05AX05 (inosine pranobex), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Inosine pranobex · ATC J05AX05
7 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Ireland
- Japan
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Inosinum pranobexum
- Manufacturer
- Gedeon Richter Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- J05AX05
- ATC class
- Inosine pranobex
- Defined daily dose
- 3 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05907594032750
- gtin05907594032767
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Inosine pranobex in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaISOPRINOSINEEwopharma International, s.r.o., Bratislava
- NorwayImunovirNewport Pharmaceuticals Ltd
- BelgiumIsoprinosine 500 mgSanofi Belgium
- CanadaIMUNOVIRKORA HEALTHCARE
- Japanイノシンプラノベクス持田製薬
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Bulgaria · Pranosine Forte, Аквир С Вкус На Ягода
- Czechia · Isoprinosine
- United Kingdom (Northern Ireland) · Imunovir
- Hungary · Inosine Pranobex Q Pharma Kft., Isoprinosine
- Ireland · Imunovir
- Lithuania · Isoprinosine
- Latvia · Isoprinosine
- Romania · Groprinosin, Inovira
- Slovakia · Inomed, Isoprinosine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ffc1cbb2-9c32-4862-af98-21a718969643 GET /v1/drugs/ffc1cbb2-9c32-4862-af98-21a718969643?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "1000 mg",
"packaging": "05907594032750 ¦ OTC ¦ 137433\n10 tabl.\n05907594032767 ¦ OTC ¦ 137434\n30 tabl.",
"substance": "Inosinum pranobexum 1000 mg",
"common_name": "Inosinum pranobexum",
"pl_product_id": "100425950",
"pozwolenie_nr": "26017",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about inosine pranobex.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.